Benzinga | Mar 1, 2021 07:10AM EST

Raymond James Maintains Outperform on Landos Biopharma, Announces $33 Price Target

Raymond James analyst Steven Seedhouse maintains Landos Biopharma (NASDAQ:LABP) with a Outperform and announces $33 price target.